Search

Now showing items 1-2 of 2

When to start antiretroviral therapy in children aged 2-5 years : a collaborative causal modelling analysis of cohort studies from Southern Africa

Schomaker, Michael; Egger, Matthias; Ndirangu, James; Moultrie, Harri; Technau, Karl; Cox, Vivian; Giddy, Janet; Phiri, Sam; Chimbetete, Cleophas; Wood, Robin; Gsponer, Thomas; Moore, Carolyn Bolton; Rabie, Helena; Eley, Brian; Muhe, Lulu; Penazzato, Martina; Essajee, Shaffiq; Keiser, Olivia; Davies, Mary-Ann (PLoS, 2013-11-19)

Background There is limited evidence on the optimal timing of antiretroviral therapy (ART) initiation in children 2–5 y of age. We conducted a causal modelling analysis using the International Epidemiologic Databases ...

Kaposi’s sarcoma : good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy

Hesseling, P. B.; Katayi, E.; Wharin, P.; Bardin, R.; Kouya, F.; Palmer, D.; Glenn, M.; Kruger, Mariana (Health & Medical Publishing Group, 2017)

There is little published information on effective treatment of Kaposi’s sarcoma (KS) in children in low-income countries. We prospectively treated 12 patients with an institutional review board-approved protocol consisting ...